TCL Archive In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished February 12, 1988
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive AACI Calls For New NCI Division For Centers. Other Programs, 75 Total Core Grants By 1992 May 6, 1988